NCT01294306 2016-11-29MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyNational Cancer Institute (NCI)Phase 2 Completed80 enrolled 10 charts